NASHVILLE, Tenn. / Jun 24, 2024 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:
What: | HCA Healthcare, Inc. 2Q Earnings Release Call |
When: | Tuesday, July 23, 2024 at 9:00 am central (10:00 am eastern) |
How: | Live Audio over the Internet: |
| https://investor.hcahealthcare.com/events-and-presentations/default.aspx | |
Contact:
Frank Morgan, 615-344-2688, Vice President, Investor Relations, This email address is being protected from spambots. You need JavaScript enabled to view it.
If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx.
| Last Trade: | US$303.62 |
| Daily Change: | 6.10 2.05 |
| Daily Volume: | 2,421,651 |
| Market Cap: | US$76.910B |
October 25, 2024 October 17, 2024 July 23, 2024 April 26, 2024 | |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
